From Our Readers

From Our Readers

How would you manage VTE risk in a transgender patient who needs hormone replacement...

Here’s how readers responded to a You Make the Call question about venous thromboembolism (VTE) risk in a transgender patient who needs hormone replacement...

Doing No Harm Versus the Right to Bear Arms

In our December 2017 issue, “Gun Violence: A Public Health Crisis,” we spoke with experts about the complexities of treating gun control as a...

CROs: A Universal Problem

Contract research organizations (CROs), which are used by much of the pharmaceutical industry to outsource research regulatory requirements, should be the epitomes of high-quality...

How would you treat a pregnant patient with type 2A von Willebrand disease?

Here’s how readers responded to a You Make the Call question about treatment options for a pregnant patient with type 2A von Willebrand disease. Disclaimer:...

How would you treat an older patient with pancytopenia who was diagnosed with ALL?

Here’s how readers responded to a You Make the Call question about treating a patient with acute lymphocytic leukemia who is of advanced age. Disclaimer:...

How should you treat a patient with lymphoma who developed “chemo brain” after R-CHOP...

Here’s how readers responded to a You Make the Call question about neurologic toxicity following R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). Disclaimer: ASH does not...

A Thought-Provoking Question

In our September issue, Elisabeth M. Battinelli, MD, PhD, responded to a colleague seeking advice on managing a patient who developed deep-vein thrombosis (DVT)...

How would you treat a pregnant woman with iron deficiency who has undergone bariatric...

Here’s how readers responded to a You Make the Call question about a pregnant woman with iron deficiency who has undergone bariatric surgery. Disclaimer: ASH...

Is This Case of Deep Vein Thrombosis Provoked or Unprovoked?

Here’s how readers responded to a You Make the Call question about travel-related deep vein thrombosis. Disclaimer: ASH does not recommend or endorse any specific...

Can’t We All Get Along?

In his August 2017 editorial (“Musing on Medical Marvels”), Keith Stewart, MBChB, MBA, recounted the amazing innovations in cancer treatment in the past 20...
Advertisement

Current Issue

January 2019 Annual Meeting Edition

This issue features highlights from the 2018 ASH Annual Meeting, including big data initiatives to improve prognosis in myelodysplastic syndromes, and more.